Asia Pacific Acute Pancreatitis Market Forecast to 2030 - Regional Analysis - by Offerings, Causes, and End User
아시아태평양의 급성 췌장염 시장은 2022년 6억 735만 달러로 평가되었습니다. 2030년에는 10억 7,606만 달러에 달할 것으로 예상되며, 2022-2030년간 연평균 7.4% 성장할 전망입니다.
급성 췌장염에 대한 연구 개발 활동과 인식 제고 프로그램 증가로 아시아태평양의 급성 췌장염 시장 활성화
급성 췌장염의 병인, 경과, 치료법을 조사하기 위해 전 세계적으로 광범위한 조사가 진행되고 있습니다. 국립 췌장재단(NPF)은 프로젝트당 최대 50,000달러 상당의 연구비를 지원하고 있습니다. 현재까지 NPF는 133개의 획기적인 연구 프로젝트에 500만 달러 이상을 지원했습니다. 지원금은 췌장염, 췌장암, 소아 췌장염의 진단 및/또는 치료를 위해 1년 동안 지급됩니다.
또한, 급성 췌장염의 역학 및 병태생리를 규명하기 위한 여러 국제적인 노력이 계속되고 있습니다. 따라서 아시아태평양의 급성 췌장염 시장의 기업들은 직접적 또는 간접적인 방법으로 효과적인 치료법을 개발하기 위한 급성 췌장염 관련 연구개발 활동과 인식 제고 프로그램이 매우 유익할 것으로 예상됩니다.
아태지역 급성 췌장염 시장 개요
아태지역 급성 췌장염 시장은 중국, 일본, 인도, 한국, 호주, 기타 아시아태평양으로 구분됩니다. 시장 성장의 배경에는 췌장염 환자 증가, 췌장염 치료법을 개발하는 연구자, 대중의 인식을 높이기 위한 정부의 이니셔티브 등이 있습니다. 또한, 알코올과 관련된 췌장염 사례도 이 지역 시장 성장을 가속하고 있습니다. 2022년에 발표된 'Burden of Pancreatitis and associated risk factors in China, 1990 to 2019'라는 제목의 연구에 따르면, 중국에서는 최근 췌장염의 유병률이 증가하는 추세를 보이고 있습니다. 췌장염의 질병 부담에 있어 중요한 병인(病因)이 되고 있습니다. 중국에서 알코올성 췌장염 환자는 10년 전에 비해 크게 증가했습니다. 1990년 380,018명, 2019년 493,765명의 췌장염 환자가 발생했고, 1990년부터 2019년까지 췌장염으로 인한 사망자 수도 증가해 1990년 8,976명, 2019년 10,664명을 차지했으며, 2019년 알코올 관련 췌장염으로 인한 사망자 수는 3.3명에 달했습니다. 국내 췌장염 사망자 수는 3,327.29명으로 전체 췌장염 사망자의 31.20%를 차지합니다.
아시아태평양의 급성 췌장염 시장 매출 및 2030년까지의 예측(US$Mn)
아태지역 급성 췌장염 시장 세분화
아시아태평양의 급성 췌장염 시장은 제공, 병인, 최종 사용자 및 국가별로 세분화됩니다.
제품에 따라 아시아태평양의 급성 췌장염 시장은 약물, 진단 및 기타로 분류됩니다. 진단 부문이 2022년 가장 큰 시장 점유율을 차지했습니다.
방법론에 따라 아시아태평양의 급성 췌장염 시장은 담석, 알코올 중독, 유전성 질환, 감염성 질환, 기타로 분류됩니다. 담석 부문은 2022년 가장 큰 시장 점유율을 차지했습니다.
최종 사용자별로 아시아태평양의 급성 췌장염 시장은 병원, 진단 실험실, 외래수술센터(ASC), 기타로 나뉩니다. 병원 부문이 2022년 가장 큰 시장 점유율을 차지했습니다.
국가별로 아시아태평양의 급성 췌장염 시장은 중국, 일본, 인도, 호주, 한국, 기타 아시아태평양으로 구분됩니다. 중국은 2022년 아시아태평양의 급성 췌장염 시장을 장악했습니다.
Abbott Laboratories, Baxter International Inc, Boston Scientific Corp, Dynavax Technologies Corp, Fresenius Kabi AG, GE HealthCare Technologies Inc, Koninklijke Philips NV, Medtronic Plc, Samsung Healthcare 등이 아시아태평양의 급성 췌장염 시장에서 활동하는 주요 기업 중 일부입니다.
목차
제1장 서론
제2장 주요 요약
- 주요 인사이트
- 아시아태평양의 급성 췌장염 시장 : 국가별
제3장 조사 방법
제4장 아시아태평양의 급성 췌장염 시장 구도
제5장 아시아태평양의 급성 췌장염 시장 - 주요 산업 역학
- 주요 시장 성장 촉진요인
- 주요 시장 성장 억제요인
- 주요 시장 기회
- 향후 동향
- 영향 분석
제6장 급성 췌장염 시장 - 아시아태평양 시장 분석
- 아시아태평양의 급성 췌장염 시장 매출, 2022년-2030년
제7장 아시아태평양의 급성 췌장염 시장 : 매출과 2030년까지 예측 : 제공별
- 시장 매출 점유율(2022년·2030년)
- 약물 요법
- 진단
- 기타
제8장 아시아태평양의 급성 췌장염 시장 : 매출과 2030년까지 예측 : 병인별
- 시장 매출 점유율(2022년·2030년)
- 담석증
- 알콜 중독
- 유전성 질환
- 감염증
- 기타
제9장 아시아태평양의 급성 췌장염 시장 : 매출과 2030년까지 예측 : 최종사용자별
- 시장 매출 점유율(2022년·2030년)
- 병원
- 진단실험실
- 외래수술센터(ASC)
- 기타
제10장 아시아태평양의 급성 췌장염 시장 : 국가별 분석
- 아시아태평양의 급성 췌장염 시장 : 국가별
- 중국
- 일본
- 인도
- 호주
- 한국
- 기타 아시아태평양
제11장 아시아태평양의 급성 췌장염 시장 - 업계 상황
- 아시아태평양의 급성 췌장염 시장 성장 전략
- 무기적 성장 전략
- 유기적 성장 전략
제12장 기업 개요
- Abbott Laboratories
- GE HealthCare Technologies Inc
- Samsung Healthcare
- Koninklijke Philips NV
- Baxter International Inc
- Dynavax Technologies Corp
- Fresenius Kabi AG
- Medtronic Plc
- Boston Scientific Corp
제13장 부록
LSH
The Asia Pacific acute pancreatitis market was valued at US$ 607.35 million in 2022 and is expected to reach US$ 1,076.06 million by 2030; it is estimated to grow at a CAGR of 7.4% from 2022 to 2030.
Upsurge in Number of R&D Activities and Awareness Programs on Acute Pancreatitis Fuels the Asia Pacific Acute Pancreatitis Market
Extensive research studies are being conducted globally to investigate the etiology, progress, and treatment of acute pancreatitis. The National Pancreas Foundation (NPF) provides multiple research grants worth ~US$ 50,000 per project. To date, the NPF has provided more than US$ 5 million for 133 ground-breaking research projects. A grant is awarded for a period of a year to diagnose and/or treat pancreatitis, pancreatic cancer, or pediatric pancreatitis.
Further, several ongoing international efforts are being made to define the epidemiology and pathophysiology of acute pancreatitis. Thus, R&D activities and awareness programs on acute pancreatitis for the development of effective therapies (through direct and indirect means) are expected to be highly fruitful for companies in the Asia Pacific acute pancreatitis market.
Asia Pacific Acute Pancreatitis Market Overview
The Asia Pacific acute pancreatitis market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. The market growth is attributed to factors including rising cases of pancreatitis, researchers to develop a treatment for pancreatitis, and government efforts to raise awareness among the population. In addition, alcohol-related pancreatitis cases also fuel the growth of the market in the region. The prevalence of pancreatitis has shown an upward trend in recent years in China. According to a study titled "Burden of Pancreatitis and associated risk factors in China, 1990 to 2019," published in 2022, alcohol consumption has become an important cause in the disease burden of pancreatitis in recent years in the country. In China, cases of alcoholic pancreatitis are significantly higher compared to 10 years ago. In the country, the number of pancreatitis cases was 380,018 in 1990 and 493,765 in 2019. From 1990 to 2019, the total number of deaths due to pancreatitis also increased, accounting for 8,976 in 1990 and 10,664 in 2019. In 2019, the number of deaths due to alcohol-related pancreatitis was 3,327.29 in the country, accounting for 31.20% of the total deaths due to pancreatitis.
Asia Pacific Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Asia Pacific Acute Pancreatitis Market Segmentation
The Asia Pacific acute pancreatitis market is segmented offerings, causes, end user, and country.
Based on offerings, the Asia Pacific acute pancreatitis market is segmented into medications, diagnosis, and others. The diagnosis segment held the largest market share in 2022.
Based on method, the Asia Pacific acute pancreatitis market is segmented into gallstones, alcoholism, genetic disorders, infection, and others. The gallstones segment held the largest market share in 2022.
Based on end user, the Asia Pacific acute pancreatitis market is divided into hospitals, diagnostic laboratories, ambulatory surgical centres, and others. The hospitals segment held the largest market share in 2022.
Based on country, the Asia Pacific acute pancreatitis market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific acute pancreatitis market in 2022.
Abbott Laboratories, Baxter International Inc, Boston Scientific Corp, Dynavax Technologies Corp, Fresenius Kabi AG, GE HealthCare Technologies Inc, Koninklijke Philips NV, Medtronic Plc, and Samsung Healthcare are some of the leading companies operating in the Asia Pacific acute pancreatitis market.
Table Of Contents
1. Introduction
- 1.1 The Insight Partners Research Report Guidance
- 1.2 Market Segmentation
2. Executive Summary
- 2.1 Key Insights
- 2.2 Asia Pacific Acute Pancreatitis Market, by Country (US$ Million)
3. Research Methodology
- 3.1 Coverage
- 3.2 Secondary Research
- 3.3 Primary Research
4. Asia Pacific Acute Pancreatitis Market Landscape
5. Asia Pacific Acute Pancreatitis Market - Key Industry Dynamics
- 5.1 Key Market Drivers
- 5.1.1 Rise in Pancreatic Cancer Cases Due to Acute Pancreatitis
- 5.1.2 Rising Incidence of Diabetes Following Acute Pancreatitis
- 5.2 Key Market Restraints
- 5.2.1 Side Effects of Pancreatitis and Pancreatic Cancer Treatments
- 5.3 Key Market Opportunities
- 5.3.1 Upsurge in Number of R&D Activities and Awareness Programs on Acute Pancreatitis
- 5.4 Future Trends
- 5.4.1 Advancements in Specific Acute Pancreatitis Treatments
- 5.5 Impact Analysis:
6. Acute Pancreatitis Market - Asia Pacific Market Analysis
- 6.1 Asia Pacific Acute Pancreatitis Market Revenue (US$ Mn), 2022 - 2030
7. Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 - by Offerings
- 7.1 Overview
- 7.2 Asia Pacific Acute Pancreatitis Market Revenue Share, by Offerings, 2022 & 2030 (%)
- 7.3 Medications
- 7.3.1 Overview
- 7.3.2 Medications: Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
- 7.3.2.1 Asia Pacific Acute Pancreatitis Market, by Medications, 2020-2030 (US$ Million)
- 7.4 Diagnosis
- 7.4.1 Overview
- 7.4.2 Diagnosis: Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
- 7.4.2.1 Asia Pacific Acute Pancreatitis Market, by Diagnosis, 2020-2030 (US$ Million)
- 7.5 Others
- 7.5.1 Overview
- 7.5.2 Others: Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
8. Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 - by Causes
- 8.1 Overview
- 8.2 Asia Pacific Acute Pancreatitis Market Revenue Share, by Causes 2022 & 2030 (%)
- 8.3 Gallstones
- 8.3.1 Overview
- 8.3.2 Gallstones: Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
- 8.4 Alcoholism
- 8.4.1 Overview
- 8.4.2 Alcoholism: Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
- 8.5 Genetic Disorders
- 8.5.1 Overview
- 8.5.2 Genetic Disorders: Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
- 8.6 Infections
- 8.6.1 Overview
- 8.6.2 Infections: Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
- 8.7 Others
- 8.7.1 Overview
- 8.7.2 Others: Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
9. Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 - by End User
- 9.1 Overview
- 9.2 Asia Pacific Acute Pancreatitis Market Revenue Share, by End User, 2022 & 2030 (%)
- 9.3 Hospitals
- 9.3.1 Overview
- 9.3.2 Hospitals: Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
- 9.4 Diagnostic Laboratories
- 9.4.1 Overview
- 9.4.2 Diagnostic Laboratories: Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
- 9.5 Ambulatory Surgical Centers
- 9.5.1 Overview
- 9.5.2 Ambulatory Surgical Centers: Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
- 9.6 Others
- 9.6.1 Overview
- 9.6.2 Others: Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
10. Asia Pacific Acute Pancreatitis Market - Country Analysis
- 10.1 Overview
- 10.1.1.1 Asia Pacific Acute Pancreatitis Market, by Country
- 10.1.1.2 China
- 10.1.1.2.1 Overview
- 10.1.1.2.2 China: Asia Pacific Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
- 10.1.1.2.3 China: Asia Pacific Acute Pancreatitis Market, by Offerings, 2020-2030 (US$ Million)
- 10.1.1.2.3.1 China: Asia Pacific Acute Pancreatitis Market, For Medications by Offerings, 2020-2030 (US$ Million)
- 10.1.1.2.3.2 China: Asia Pacific Acute Pancreatitis Market, For Diagnosis by Offerings, 2020-2030 (US$ Million)
- 10.1.1.2.4 China: Asia Pacific Acute Pancreatitis Market, by Causes, 2020-2030 (US$ Million)
- 10.1.1.2.5 China: Asia Pacific Acute Pancreatitis Market, by End User, 2020-2030 (US$ Million)
- 10.1.1.3 Japan
- 10.1.1.3.1 Overview
- 10.1.1.3.2 Japan: Asia Pacific Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
- 10.1.1.3.3 Japan: Asia Pacific Acute Pancreatitis Market, by Offerings, 2020-2030 (US$ Million)
- 10.1.1.3.3.1 Japan: Asia Pacific Acute Pancreatitis Market, For Medications by Offerings, 2020-2030 (US$ Million)
- 10.1.1.3.3.2 Japan: Asia Pacific Acute Pancreatitis Market, For Diagnosis by Offerings, 2020-2030 (US$ Million)
- 10.1.1.3.4 Japan: Asia Pacific Acute Pancreatitis Market, by Causes, 2020-2030 (US$ Million)
- 10.1.1.3.5 Japan: Asia Pacific Acute Pancreatitis Market, by End User, 2020-2030 (US$ Million)
- 10.1.1.4 India
- 10.1.1.4.1 Overview
- 10.1.1.4.2 India: Asia Pacific Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
- 10.1.1.4.3 India: Asia Pacific Acute Pancreatitis Market, by Offerings, 2020-2030 (US$ Million)
- 10.1.1.4.3.1 India: Asia Pacific Acute Pancreatitis Market, For Medications by Offerings, 2020-2030 (US$ Million)
- 10.1.1.4.3.2 India: Asia Pacific Acute Pancreatitis Market, For Diagnosis by Offerings, 2020-2030 (US$ Million)
- 10.1.1.4.4 India: Asia Pacific Acute Pancreatitis Market, by Causes, 2020-2030 (US$ Million)
- 10.1.1.4.5 India: Asia Pacific Acute Pancreatitis Market, by End User, 2020-2030 (US$ Million)
- 10.1.1.5 Australia
- 10.1.1.5.1 Overview
- 10.1.1.5.2 Australia: Asia Pacific Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
- 10.1.1.5.3 Australia: Asia Pacific Acute Pancreatitis Market, by Offerings, 2020-2030 (US$ Million)
- 10.1.1.5.3.1 Australia: Asia Pacific Acute Pancreatitis Market, For Medications by Offerings, 2020-2030 (US$ Million)
- 10.1.1.5.3.2 Australia: Asia Pacific Acute Pancreatitis Market, For Diagnosis by Offerings, 2020-2030 (US$ Million)
- 10.1.1.5.4 Australia: Asia Pacific Acute Pancreatitis Market, by Causes, 2020-2030 (US$ Million)
- 10.1.1.5.5 Australia: Asia Pacific Acute Pancreatitis Market, by End User, 2020-2030 (US$ Million)
- 10.1.1.6 South Korea
- 10.1.1.6.1 Overview
- 10.1.1.6.2 South Korea: Asia Pacific Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
- 10.1.1.6.3 South Korea: Asia Pacific Acute Pancreatitis Market, by Offerings, 2020-2030 (US$ Million)
- 10.1.1.6.3.1 South Korea: Asia Pacific Acute Pancreatitis Market, For Medications by Offerings, 2020-2030 (US$ Million)
- 10.1.1.6.3.2 South Korea: Asia Pacific Acute Pancreatitis Market, For Diagnosis by Offerings, 2020-2030 (US$ Million)
- 10.1.1.6.4 South Korea: Asia Pacific Acute Pancreatitis Market, by Causes, 2020-2030 (US$ Million)
- 10.1.1.6.5 South Korea: Asia Pacific Acute Pancreatitis Market, by End User, 2020-2030 (US$ Million)
- 10.1.1.7 Rest of Asia Pacific
- 10.1.1.7.1 Overview
- 10.1.1.7.2 Rest of Asia Pacific: Asia Pacific Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
- 10.1.1.7.3 Rest of Asia Pacific: Asia Pacific Acute Pancreatitis Market, by Offerings, 2020-2030 (US$ Million)
- 10.1.1.7.3.1 Rest of Asia Pacific: Asia Pacific Acute Pancreatitis Market, For Medications by Offerings, 2020-2030 (US$ Million)
- 10.1.1.7.3.2 Rest of Asia Pacific: Asia Pacific Acute Pancreatitis Market, For Diagnosis by Offerings, 2020-2030 (US$ Million)
- 10.1.1.7.4 Rest of Asia Pacific: Asia Pacific Acute Pancreatitis Market, by Causes, 2020-2030 (US$ Million)
- 10.1.1.7.5 Rest of Asia Pacific: Asia Pacific Acute Pancreatitis Market, by End User, 2020-2030 (US$ Million)
11. Asia Pacific Acute Pancreatitis Market-Industry Landscape
- 11.1 Overview
- 11.2 Growth Strategies in the Asia Pacific Acute Pancreatitis Market
- 11.3 Inorganic Growth Strategies
- 11.4 Organic Growth Strategies
12. Company Profiles
- 12.1 Abbott Laboratories
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
- 12.2 GE HealthCare Technologies Inc
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
- 12.3 Samsung Healthcare
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
- 12.4 Koninklijke Philips NV
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
- 12.5 Baxter International Inc
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
- 12.6 Dynavax Technologies Corp
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
- 12.7 Fresenius Kabi AG
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
- 12.8 Medtronic Plc
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
- 12.9 Boston Scientific Corp
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
13. Appendix
- 13.1 About Us
- 13.2 Glossary of Terms
